EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. recorded $1,259,266,758.71 in obligated awards across 65 actions, averaging $19,373,334.74 per action. Most obligations were awarded by the Office of Assistant Secretary for Preparedness and Response, with additional activity from the Defense Health Agency, the National Institutes of Health, and the Department of the Army.
Federal Contractor
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Federal Contract Obligations (Last 5 Years)
Federal procurement profile for EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (CAGE 057Y1, UEI CNPVCR8DK7M8) covering awards in the last five years.
Agency, NAICS, and annual totals reflect obligated amounts in the five-year analysis window and may include negative values for deobligations.
CAGE Code
057Y1
UEI
CNPVCR8DK7M8
Total Obligated
1.26 billion
1,259,266,758.71
Award Actions
65
Average Action Value
19,373,334.74
About EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. federal contract activity
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (CAGE 057Y1, UEI CNPVCR8DK7M8) recorded 65 awards and $1.26 billion in total obligations over the last 5 years, for an average award value of about $19.37 million. Funding is highly concentrated, with most obligated dollars tied to a small number of awards rather than a broad spread across many agencies or procurement categories.
Agency mix and customer concentration
The award portfolio is dominated by the OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, which accounts for $1.25 billion across 48 awards and represents nearly all observed obligations. Secondary activity is limited and much smaller, with modest obligations from the DEFENSE HEALTH AGENCY and the NATIONAL INSTITUTES OF HEALTH, while the DEPT OF THE ARMY shows net negative obligations over the period, indicating downward adjustments or deobligations.
Industry profile based on NAICS activity
The vendor’s obligations are concentrated in biotechnology-related research and manufacturing. NAICS 541711 and 325414 together account for the bulk of total obligated dollars, while 541714 provides additional biotech R&D volume; the remaining NAICS categories are comparatively minor and suggest only limited activity outside the core life sciences and biotechnology profile.
Annual contract trend over the analysis window
Obligations peaked in 2021 at $590.64 million across 20 awards, then fell sharply in 2022 before rebounding in 2023 and 2024. The 2025 level remains substantial at $102.67 million across 6 awards, but it is well below the 2021 high and below the 2023 and 2024 totals, indicating a volatile year-to-year funding pattern.
How to interpret this page
This summary uses FPDS award records for the last 5 years and reflects total obligated dollars, award counts, and obligation patterns by agency, NAICS code, and fiscal year. Negative obligations are presented as recorded and may reflect modifications, deobligations, or other contract adjustments rather than new award activity.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '057Y1'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 7505 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | 1,254,903,701.57 | 1.25 billion | 48 |
| 97DH | DEFENSE HEALTH AGENCY (DHA) | 6,787,811.64 | 6.79 million | 1 |
| 7529 | NATIONAL INSTITUTES OF HEALTH | 5,305,508.33 | 5.31 million | 9 |
| 2100 | DEPT OF THE ARMY | -7,730,262.83 | -7.73 million | 7 |
Insight
Over the last 5 years, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. received $1.26 billion across 65 awards, with an average award value of $19.37 million. Obligation is highly concentrated in the Office of Assistant Secretary for Preparedness and Response, which accounts for $1.25 billion and 48 awards, or nearly all recorded obligations in this period. Other agencies contributed only marginally in positive obligations: the Defense Health Agency at $6.79 million on 1 award and the National Institutes of Health at $5.31 million on 9 awards. The Dept of the Army shows negative obligations of $7.73 million across 7 awards, indicating downward adjustment activity within the period.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '057Y1'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | 679,212,387.59 | 679.21 million | 28 |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 458,576,057.46 | 458.58 million | 12 |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 118,563,679.00 | 118.56 million | 10 |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | 3,107,825.88 | 3.11 million | 5 |
| 541710 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES | 749,259.97 | 749.26 thousand | 2 |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | -942,451.19 | -942.45 thousand | 8 |
Insight
Over the last 5 years, obligations for EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. are highly concentrated in biotechnology-related NAICS codes. NAICS 541711 accounts for the largest share at $679.21 million across 28 awards, followed by 325414 at $458.58 million across 12 awards and 541714 at $118.56 million across 10 awards; together these three codes represent nearly all reported obligations. Smaller obligations appear in 541712, 541710, and 541715, with 541715 reflecting a net negative obligated amount of $942.45 thousand.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '057Y1'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 102,674,751.00 | 102.67 million | 6 |
| 2024 | 220,331,914.61 | 220.33 million | 15 |
| 2023 | 323,899,310.66 | 323.90 million | 13 |
| 2022 | 21,719,090.92 | 21.72 million | 11 |
| 2021 | 590,641,691.52 | 590.64 million | 20 |
Insight
Over the last 5 years, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. received $1.26 billion across 65 awards, averaging $19.37 million per award. Obligations were highly concentrated in 2021 ($590.64 million) and 2023 ($323.90 million), which together account for most of the period total, while 2022 was a pronounced low point at $21.72 million. Activity remained substantial in 2024 ($220.33 million across 15 awards) and declined further in 2025 year-to-date to $102.67 million across 6 awards.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 5 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.